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Introduction
 Ovarian cancer happens to be the second most 
common malignancy that accounts for 4% of all cancers 
in female population. Annually more than 190,000 new 
cases are diagnosed world over with the life time risk of 
developing ovarian cancer in India is 0.75% which vary 
considerably world over (Parkin et al., 2003; Jemal et al., 
2008). However the mortality is the highest in comparison 
to the other gynecological cancers. 
 Different investigation tools such as serum CA-125 and 
pelvic examinations over a period of past many years have 
been tested and shown lower sensitivities in the diagnosis 
of ovarian masses. Owing to this and high mortality 
rate associated with ovarian malignancy, ultrasound 
has attained its role as the most important preliminary 
investigation of choice to rule out ovarian malignancies 
with sensitivity ranging from 80-100% (Kinkle et al., 
2000; Van Calster et al., 2005; Arab et al., 2012).
 Although, Doppler ultrasound allows detection of 
tumor flow. However, its role has not been found consistent 
in diagnosis of malignancy (Kinkle et al., 2005; Liu et al., 
2007). Moreover, there exists a wide variation in patient 
population, imaging techniques, and results making things 
more complicated to precisely understand and assess the 
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Abstract
 Background: Ovarian cancer is the second most common malignancy in Pakistani women, accounting for 4% 
of all cancers in the female population. The aim of this study was to determine sensitivity, specificity, positive and 
negative predictive values and 95% confidence intervals for ultrasound in characterization of ovarian masses in 
patients presenting at public and private tertiary care hospitals in Karachi, Pakistan. Materials and Methods: 
We adopted a cross-sectional analytical study design to retrospectively collect data from January 2009-11 from 
medical records of two tertiary care hospitals. Using a non-probability purposive sampling technique, we 
recruited a sample of 86 women aged between 15 and 85 years fulfilling inclusion criteria with histopathologically 
proven ovarian masses presenting for an ultrasound examination in our radiology departments. Results: Our 
retrospective data depicted sensitivity and specificity of ultrasound to be 90.7%, 95%CI (0.77, 0.97) and 91.4%, 
95%CI (0.76, 0.98) respectively. Positive predictive value was 93%, 95%CI (0.79, 0.98) and negative predictive 
value was 89%, 95%CI (0.73, 0.96). A total of 78 ovarian masses were detected, out of which 42 were malignant 
and 36 were benign. Conclusions: Results of our study further reinforce the conclusion that ultrasound should 
be used as an initial modality of choice in the workup of every woman suspected of having an ovarian mass. It 
not only results in decreasing the mortality but also avoids unnecessary surgical interventions. 
Keywords: Ovarian masses - ultrasound characterization - Pakistan females
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diagnostic ability of existing various imaging techniques.
 Ultrasound features of malignant ovarian masses 
are (Ameye et al., 2009): Cysts with thickened and 
irregular walls, internal septae (>3 mm), vegetation or 
papillary projections, cystic lesions greater than 10 cm 
diameter, presence of solid components or completely 
solid lesions. Other associated signs include ascites or 
peritoneal deposits. Based on these features (Sassone et 
al., 1991) derived a scale which focused on the features 
such as echo pattern of the lesion, presence or absence of 
papillary projection and septae, and wall thickness. As a 
result they distinguished benign and malignant masses 
with sensitivity of 100%, and specificity of 83%. Similarly 
(Jacobs et al., 1990) showed 85% sensitivity and 97% 
specificity of ultrasound for the detection of malignancy. 
In 1999, International Ovarian Tumor Analysis Group 
performed a study which included multiple centers 
from five European countries. They collected relevant 
demographic and radiographic data of more than 1,000 
patients presenting with persistent adnexal masses 
prospectively and developed a mathematic model so that 
the risk of  risk of malignancy in an adnexal mass can be 
calculated, with an area under the receiver operating curve 
(ROC) of 0.96 (Timmerman et al., 2005).
 In 2007, the same group reported sensitivity and 
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specificity of morphologic features of ovarian masses on 
ultrasound to be 90% and 88% respectively.
 The largest randomized controlled trial conducted by 
United Kingdom collaborative Trial of ovarian Cancer 
screening published their results of ovarian cancer 
screening in April 2009. They included more than 200,000 
postmenopausal women in their study and reported 
ultrasound to be 84.9% sensitive for the detection of 
ovarian malignancy (Menon et al., 2009).
 In spite of such an extensive research work and 
international data available with regards to the diagnostic 
accuracy of ultrasound in detection of both benign 
and malignant ovarian masses, to our surprise the 
literature from this part of the world appears scarce. No 
comprehensive study has been conducted in the recent 
past that emphasizes the significance of such a novel and 
yet effective investigative tool in detection of malignancy 
which is so fatal. We, therefore studied whether ultrasound 
is sensitive in characterization of ovarian masses in women 
(15-85 years) presenting at public and private tertiary 
care hospitals in Karachi? We hope that results of this 
study will encourage concerned personnel to expedite 
specific actions required to teach and train appropriate 
techniques to those who are routinely carrying out such 
ultrasounds as early detection and accurate staging will 
not only improve the disease prognosis but would also 
help avoiding excessive radiation examinations in those 
who would neither benefit nor require them. 
 
Materials and Methods
 A cross-sectional analytical study was designed to 
retrospectively collect data from Jan 2009-Jan 2011 by 
non-probability purposive sampling technique. Women 
aged between 15 and 85 years were included if referred/
presented for an ultrasound examination in radiology 
departments of two tertiary care hospitals in Karachi. Pre 
and post-menopausal women having both ultrasound and 
histopathology records of ovarian masses were recruited in 
the study. Medical records (histopathology and ultrasound 
reports) for ovarian masses were seen during this study 
period. They were excluded if diagnosed as ovarian mass 
on ultrasound but no histopathology report. They were 
also excluded if patients presented with histopathology 
positive for ovarian mass without ultrasound reports and 
if presented with recurrent or residual ovarian mass.After 
permission from radiology departmental heads of tertiary 
care hospitals and Ethical Review Committee exemption; 
data collection process was commenced. Confidentiality of 
patients’ records was assured and maintained throughout 
the study. Ultrasound reports from medical records of 
patients with proven ovarian mass on histopathology 
were analyzed. All the ultrasounds were performed 
on NEMIO XG, TOSHIBA machines by a radiologist 
having at least 3 years of experience in performing pelvic 
ultrasounds. Trans abdominal scans were done using 3.5 
MHz probe. Where ever required transvaginal scanning 
was also performed using 7.5 MHz frequency probe 
using the same machine in the single setting in both the 
centers. Data were collected in structured proforma which 
elicited information regarding patient’s demographics 
and ultrasound characteristics of the ovarian mass. Final 
diagnosis was confirmed on histopathology taken as gold 
standard.
Sample size calculation
 Calculated sensitivity of ultrasound for the  detection 
of ovarian carcinoma is 80% (Jain, 1994; Jung et al., 2002) 
taking confidence interval of 95% , bound on error of 9%, 
the calculated sample size N=76. n= [Z2
1-α/2
 - P (1-P)]/B2.
Plan of analysis
 Data were entered and analyzed using SPSS windows 
package version 19.0. Frequencies were generated and 
proportions reported for qualitative variables. Mean and 
standard deviation computed for quantitative variables 
such as age. Sensitivity and specificity of the ultrasound 
for ovarian masses was calculated and 95% Confidence 
Intervals (CI) reported. Positive and negative predictive 
values were also computed.
Results 
 Results gathered from our retrospective data depicted 
sensitivity and specificity of ultrasound to be 90.7%, 95%CI 
(0.77, 0.97) and 91.4%, 95%CI (0.76, 0.98) respectively in 
characterization of benign and malignant ovarian masses. 
The age range of patients was between 16-86 years with 
mean age of 40.95±SD 16.54. The mean tumor size was 
7.6±4.03 x 6.1±3.13 in transverse and longitudinal axis 
respectively for the left ovary and 7.9±4.22 x 6.5±3.00 
for the right ovary. Positive predictive value was 93%, 
95%CI (0.79, 0.98) and negative predictive value was 
89%, 95%CI (0.73, 0.96). Data were collected of 84 
women with the diagnosis of ovarian masses over a period 
of two years from both hospital excluding six such cases 
for certain specific  reasons. Reasons for exclusion were 
histopathologically inadequate sample in two and non-
specific tissue in others. 49% of the tumors (42/78) were 
malignant, rest (36/78) were benign. The histopathological 
diagnoses of benign and malignant ovarian masses are 
shown in Table 2. Out of 42 malignant tumors diagnosed 
on ultrasound, 3 were histopathologically proven benign. 
Their final diagnoses were as follows: (n=1) serous cyst 
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Table 1. Historical Comparisons of Ultrasound and Clinical Criteria for Cancer Prediction
Study No. of Patients Characteristics Accuracy
Sassone et al. 1991 143 Gray-scale characteristics score Sensitivity, 100%; specificity 83%; PPV, 37%; NPV, 100%
Fleischer et al. 1993 50 Color and spectral Doppler characteristics Pulsatility index; sensitivity, 100%; specificity, 82%; PPV, 73%; NPV, 100%
UKCTOCS, 2009 50,640 Multitechnique screening Sensitivity, 89%; specificity, 99%; PPV, 35%; NPV, 99%
  (ultrasound and serum CA-125) AUC=0 0.96; pattern recognition: sensitivity, 90%; specificity, 88% and
IOTA, 2005 1,573 Combined gray-scale and color mapping,  logistic regression: sensitivity, 95%; specificity, 74% and subgroup
  age, and other clinical variables category: sensitivity, 88%, specificity 90%
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adenomas, (n=2) hemorrhagic cysts. Similarly, benign 
diagnosis was suggested in 36 tumors out of which 32 
were found to be in concordance with histopathology. 
Those were: endometriomas (n=19), dermoid cyst (n=1), 
Para ovarian cyst (n=3), tubo-ovarian abscess (n=2), 
hemorrhagic cyst (n=6), simple ovarian cysts (n=5). The 
true positive rate of endometriosis was (17/19), of dermoid 
cyst (0/1), of tubo-ovarian abscess/inflammation disease 
(2/2), of Para ovarian cyst (3/3). The incorrect diagnoses 
of endometrioma represented one mucinous cystadenoma, 
one mature cystic teratoma; the one incorrect diagnoses 
of dermoid cyst comprised one mature cystic teratoma; 
the 1 incorrect diagnoses of ovarian hemorrhagic cyst 
represented ovarian endometriosis. Thus, ultrasound was 
able to make 39 correct specific malignant diagnosis and 
32 of benign masses.
 
Discussion
Ultrasonography (US) has established and developed 
itself as the most important preliminary imaging tool in 
identification and characterization of the ovarian masses. 
This has eliminated unnecessary surgeries in those who 
will not get any benefit out of it. Both Trans abdominal and 
transvaginal techniques along with Doppler examination 
provides optimal visualization of ovarian masses (Fleicher 
et al., 1993). In the current study, mixture of both benign 
and malignant ovarian masses was present. Most of the 
benign lesions such as endometriomas, simple ovarian/
Para ovarian cysts, dermoid cysts, hemorrhagic cysts 
and tubo-ovarian infections were specifically diagnosed. 
However, malignancies and certain benign solid masses 
were not further sub classified into teratomas, sarcomas, 
ovarian fibromas, serous and mucinous cyst adenomas. 
As from a clinical perspective it has been found sufficient 
to suggest a benign solid ovarian tumor diagnosis rather 
than to be more specific (Jermy et al., 2001).
Therefore based on the sonological features and 
available clinical data we made a correct specific diagnosis 
of 91% of the tumors. This was very much in concordance 
with other international studies reporting the sensitivities 
and specificities between 85-100% (Buy et al., 1993; 
Nishat et al., 2011).
Despite the fact that endometriomas are known 
to exhibit certain classical sonographic features such 
as a ‘ground glass’ appearance and low level internal 
echoes (Aleem et al.,1995) we came across both false-
positives  and false-negatives cases. One cases of ovarian 
mucinous cyst adenoma and one hemorrhagic cysts 
were inaccurately labeled as endometriotic cysts (false-
positives).  In the present series, therefore the true positive 
rate for this diagnosis is 90%.  
Although such overlaps and confusions have also 
existed in the past in the literature as well between 
endometriomas and cyst adenomas, dermoid and 
hemorrhagic cysts on sonography. However, our results 
report true-positive rate of 90%. Guerriero et al (1995). 
has reported sensitivity as 83% (Guerriero et al., 1995).
Similarly one of the mature cystic teratoma was 
wrongly diagnosed as a dermoid cyst making the 
sensitivity of our imaging to be 0%. This figure does not 
depict the actual sensitivity and specificity as we had only 
a single case of dermoid. Reported sensitivity by Mais et 
al. (1995) ranged from 53-100% (Mais et al., 1995). 
In the present series, there were no incorrect diagnoses 
of Para ovarian cyst. One hemorrhagic cyst was misjudged 
on imaging as an endometrioma (false-positive). There 
have been no reports of the specificity of ultrasound in 
the diagnosis of Para ovarian cysts or of the sensitivity 
and specificity of gray-scale imaging in the diagnosis 
of peritoneal cysts. We did not come across a peritoneal 
cyst in our collected data. Our present series of tumors 
included only two tubo-ovarian abscesses. One was 
correctly diagnosed; the other was misdiagnosed as an 
abscess originating from appendicitis (false-negative). 
Given the complex appearances and echo patterns of 
tubo-ovarian abscesses as well as absence of relevant 
clinical information, such confusions are not unexpected 
(Fleischer et al., 1992). No reports exist in the literature 
so far regarding the diagnostic accuracy of pelvic abscess. 
Only Fleischer et al have reported the diagnostic accuracy 
of ultrasound for diagnosing tubal disease as 83% sensitive 
and 73% specific.
Several studies define Doppler findings of endometriotic 
cysts, dermoid cysts, tubo-ovarian abscesses and other 
benign cysts (Aleem et al., 1995; Zalel et al., 1997; Pascual 
et al., 2000). However, none have proved to be consistent. 
In our series of patients, we used Doppler sonography 
wherever the radiologist would think its usefulness would 
greatly impact in making the diagnosis and at the same 
time not following any specified criteria. 
However, the problem with both ultrasound and 
Table 2. Histopathological Diagnoses of Tumors
Histopathological diagnoses No. (%)
Benign: Ovarian cyst 5 (12.8 )
 Serous cyst adenoma 3  (3.84)
 Mucinous cyst adenoma 2  (2.5)
 Tubovarian inflammation 2  (2.5)
 Corpus albicantes 3  (3.84)
 Corpus haemorrhagicum 2  (2.5)
 Corpus luteal cyst 3  (3.8)
 Para tubal cyst 5  (6.4)
 Endometrioma 19 (24.4)
Malignant: Adenocarcinoma 11(14.1)
 Ovarian carcinoma 3  (3.8)
 Clear cell carcinoma 1  (1.3)
 Endometriod carcinoma 4  (5.1)
 Mature cystic teratoma 3  (3.8)
 Papillary carcinoma 2  (2.5)
 Spindle cell tumor  2  (2.5)
 Serous cyst adenocarcinoma 2  (2.5)
Table 3. Sensitivity of Ultrasound in Differentiating 
between Benign and Malignant Ovarian Masses
Diagnosis Sensitivity (%)
Malignancy 93 (39/42) 
Endometriosis 90 (17/19)
Dermoid cyst 00     (0/1)
Para ovarian or Para tubal cyst 100     (3/3)
Tubo-ovarian abscess 100     (2/2)
Simple ovarian/hemorrhagic cyst 91 (10/11)
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Doppler examination is its operator as well as equipment 
dependency, and whether the results obtained from one type 
of equipment are pertinent to other system. Furthermore, 
we would have to perform multiple studies prospectively 
on a larger scale with larger patient population to assess 
the reliability of both forms of imaging, that is, color 
Doppler and grey scale imaging independently as well 
as concurrently with a predefined criteria in determining 
the diagnosis of ovarian masses (Van Nagell et al., 2007). 
Knowledge of the exact nature of a pelvic mass after 
ultrasound examination is also a prerequisite for effective 
management, surgical or non- surgical. Since this fact 
has been established well by literature that exclusion of 
ovarian malignancy with precise ultrasound information 
goes a long way in the future management and also helps 
avoiding needless surgical interventions not giving any 
benefit to them.
In conclusion, this study yielded the diagnostic 
accuracy of ultrasound to be 91% in the diagnosis of 
ovarian masses, thus increasing its reliability. Thus 
ultrasound seems to be an initial modality of choice in the 
workup of every woman suspected of having an ovarian 
mass. And, to rule out unnecessary surgical interventions 
in benign masses.
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